134 related articles for article (PubMed ID: 7482818)
1. Effectiveness of combination prophylaxis with cytomegalovirus hyperimmune globulin and acyclovir in the high-risk kidney transplant recipient.
Uber L; Cofer J; Baliga P; Rajagopalan PR
Transplant Proc; 1995 Oct; 27(5 Suppl 1):42-3. PubMed ID: 7482818
[No Abstract] [Full Text] [Related]
2. Cytomegalovirus prophylaxis with ganciclovir, acyclovir, and CMV hyperimmune globulin in liver transplant patients receiving OKT3 induction.
Ham JM; Shelden SL; Godkin RR; Posner MP; Fisher RA
Transplant Proc; 1995 Oct; 27(5 Suppl 1):31-3. PubMed ID: 7482814
[No Abstract] [Full Text] [Related]
3. Cytomegalovirus prophylaxis by ganciclovir followed by high-dose acyclovir in renal transplantation: a randomized, controlled trial.
Pouteil-Noble C; Megas F; Chapuis F; Bosshard S; Colin C; Hadj-Aissa A; Pozet N; Martin X; Lefrançois N; Garnier JL; Aymard M; Touraine JL
Transplant Proc; 1996 Oct; 28(5):2811. PubMed ID: 8908072
[No Abstract] [Full Text] [Related]
4. Prophylactic immunoglobulin therapy improves the outcome of renal transplantation in recipients at risk for primary cytomegalovirus disease.
Conti DJ; Freed BM; Lempert N
Transplant Proc; 1993 Feb; 25(1 Pt 2):1421-2. PubMed ID: 8382867
[No Abstract] [Full Text] [Related]
5. Cytomegalovirus prophylaxis with intravenous polyvalent immunoglobulin in high-risk renal transplant recipients.
Leroy F; Sechet A; Abou Ayache R; Thierry A; Belmouaz S; Desport E; Bauwens M; Bridoux F; Touchard G
Transplant Proc; 2006 Sep; 38(7):2324-6. PubMed ID: 16980080
[TBL] [Abstract][Full Text] [Related]
6. Combined antiviral and immunoglobulin therapy as prophylaxis against cytomegalovirus infection after heart transplantation.
Valenza M; Czer LS; Pan SH; Aleksic I; Freimark D; Harasty DA; Admon D; Barath P; Blanche C; Trento A
J Heart Lung Transplant; 1995; 14(4):659-65. PubMed ID: 7578172
[TBL] [Abstract][Full Text] [Related]
7. Incidence of infection and acute rejection after cytomegalovirus immune globulin prophylaxis in renal transplantation.
Basadonna G; Feria A; Perez R; Klein H; Sturges M; Colquhoun S
Transplant Proc; 1994 Oct; 26(5 Suppl 1):52-3. PubMed ID: 7940976
[No Abstract] [Full Text] [Related]
8. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.
Rubin RH; Kemmerly SA; Conti D; Doran M; Murray BM; Neylan JF; Pappas C; Pitts D; Avery R; Pavlakis M; Del Busto R; DeNofrio D; Blumberg EA; Schoenfeld DA; Donohue T; Fisher SA; Fishman JA
Transpl Infect Dis; 2000 Sep; 2(3):112-7. PubMed ID: 11429021
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic cytomegalovirus management strategies.
Martin M
Transplant Proc; 1995 Oct; 27(5 Suppl 1):23-7. PubMed ID: 7482812
[No Abstract] [Full Text] [Related]
10. Prevention of cytomegalovirus disease in heart transplant recipients by prophylaxis with cytomegalovirus hyperimmune globulin plus oral acyclovir.
Eisenmann D; Knipp H; Laube H; Stegmann T
Transplant Proc; 1990 Oct; 22(5):2322-3. PubMed ID: 2171169
[No Abstract] [Full Text] [Related]
11. Effect of cytomegalovirus prophylaxis with acyclovir on renal transplant survival.
Abraham KA; O'Kelly P; Spencer S; Hickey DP; Conlon PJ; Walshe JJ
Ren Fail; 2008; 30(2):141-6. PubMed ID: 18300112
[TBL] [Abstract][Full Text] [Related]
12. Incidence and therapy of cytomegalovirus disease after liver transplantation.
Wiens M; Lefèbre B; Blumhardt G; Schmidt CA; Lohmann R; Neuhaus P
Transplant Proc; 1993 Apr; 25(2):1985-6. PubMed ID: 8385829
[No Abstract] [Full Text] [Related]
13. Chronic rejection in kidney transplant patients receiving cytomegalovirus prophylaxis with acyclovir.
Birkeland SA; Rohr N; Elbirk A; Jørgensen KA
Transplant Proc; 1995 Jun; 27(3):2040-1. PubMed ID: 7792878
[No Abstract] [Full Text] [Related]
14. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
Cantarovich M; Durrbach A; Hiesse C; Ladouceur M; Benoit G; Charpentier B
Transplantation; 2008 Dec; 86(12):1732-7. PubMed ID: 19104413
[TBL] [Abstract][Full Text] [Related]
15. Anti-CMV hyperimmune globulin prophylaxis does not prevent CMV disease in CMV-negative renal transplant patients.
Pakkala S; Salmela K; Lautenschlager I; Ahonen J; Häyry P
Transplant Proc; 1992 Feb; 24(1):283-4. PubMed ID: 1311472
[No Abstract] [Full Text] [Related]
16. Elimination of cytomegalovirus disease in liver transplant patients treated prophylactically with combination cytomegalovirus hyperimmune globulin and ganciclovir.
Prian GW; Koep LJ
Transplant Proc; 1994 Oct; 26(5 Suppl 1):54-5. PubMed ID: 7940977
[No Abstract] [Full Text] [Related]
17. Acyclovir in preventing cytomegalovirus infection in kidney transplant recipients: a case-controlled study.
Legendre C; Ducloux D; Ferroni A; Chkoff N; Valette C; Geffrier C; Rouzioux C; Kreis H
Transplant Proc; 1993 Feb; 25(1 Pt 2):1431-3. PubMed ID: 8382871
[No Abstract] [Full Text] [Related]
18. Ganciclovir/acyclovir prophylaxis reduces the incidence of cytomegalovirus infections in pancreas transplant recipients.
Harland RC; Vernon WB; Bunzendahl H; Thompson JK; Lawrence C; Bollinger RR
Transplant Proc; 1994 Apr; 26(2):432-3. PubMed ID: 8171488
[No Abstract] [Full Text] [Related]
19. Cytomegalovirus infection in kidney transplant recipients: Evolution of approach through three eras.
Boucher A; Lord H; Collette S; Morin M; Dandavino R
Transplant Proc; 2006 Dec; 38(10):3506-8. PubMed ID: 17175316
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus disease prophylaxis in renal transplantation by high dose oral acyclovir: efficacy and limits.
Bertoni E; Rosati A; Zanazzi M; Moscarelli L; Di Maria L; Piperno R; Orsi A; Parri F; Dedola G; Salvadori M
Transplant Proc; 1998 Aug; 30(5):2094. PubMed ID: 9723402
[No Abstract] [Full Text] [Related]
[Next] [New Search]